Melbourne start-up Everlab has completed a raise to accelerate its plans to deliver preventive care and longevity solutions to the masses, rewriting the script on chronic disease.
Orthocell has made a strong addition to its board as it accelerates plans for US commercialisation, appointing highly experienced director Michael McNulty.